ERICH3: vesicular association and antidepressant treatment response

Selective serotonin reuptake inhibitors (SSRIs) are standard of care for major depressive disorder (MDD) pharmacotherapy, but only approximately half of these patients remit on SSRI therapy. Our previous genome-wide association study identified a single-nucleotide polymorphism (SNP) signal across th...

Full description

Saved in:

Bibliographic Details
Published in:	Molecular psychiatry Vol. 26; no. 6; pp. 2415 - 2428
Main Authors:	Liu, Duan, Zhuang, Yongxian, Zhang, Lingxin, Gao, Huanyao, Neavin, Drew, Carrillo-Roa, Tania, Wang, Yani, Yu, Jia, Qin, Sisi, Kim, Daniel C, Liu, Erica, Nguyen, Thanh Thanh Le, Biernacka, Joanna M, Kaddurah-Daouk, Rima, Dunlop, Boadie W, Craighead, W Edward, Mayberg, Helen S, Binder, Elisabeth B, Frye, Mark A, Wang, Liewei, Weinshilboum, Richard M
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01.06.2021
Subjects:	Antidepressants Antidepressive Agents - therapeutic use Cell culture Central nervous system Clathrin Clinical trials Culture media Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics Drug therapy Gene polymorphism Genome-wide association studies Genome-Wide Association Study Genomes Humans Immunofluorescence Isoforms Lysates Mental depression Patients Serotonin - therapeutic use Serotonin uptake inhibitors Serotonin Uptake Inhibitors - therapeutic use Single-nucleotide polymorphism Systematic review
ISSN:	1359-4184, 1476-5578, 1476-5578
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!